1. Home
  2. CWST vs GKOS Comparison

CWST vs GKOS Comparison

Compare CWST & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casella Waste Systems Inc.

CWST

Casella Waste Systems Inc.

HOLD

Current Price

$88.13

Market Cap

5.9B

Sector

Utilities

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$140.55

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWST
GKOS
Founded
1975
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.0B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
CWST
GKOS
Price
$88.13
$140.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$115.71
$126.92
AVG Volume (30 Days)
805.9K
679.9K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,836,841,000.00
$507,442,000.00
Revenue This Year
$10.95
$23.32
Revenue Next Year
$6.97
$27.43
P/E Ratio
$722.88
N/A
Revenue Growth
17.95
32.33
52 Week Low
$74.05
$73.16
52 Week High
$121.20
$146.75

Technical Indicators

Market Signals
Indicator
CWST
GKOS
Relative Strength Index (RSI) 59.44 70.09
Support Level $84.52 $80.14
Resistance Level $90.22 N/A
Average True Range (ATR) 3.24 4.92
MACD 0.91 1.86
Stochastic Oscillator 96.96 79.63

Price Performance

Historical Comparison
CWST
GKOS

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: